Commercial product
ActiPatch®
FDA 510(k) cleared (K192234), drug-free wearable for over-the-counter adjunctive treatment of musculoskeletal pain.
ActiPatch® is manufactured by BioElectronics Corporation (BIEL). Electrome holds the exclusive North American license.
From $39.99 for 720 therapy hours.
- Drug-free, nonthermal pulsed shortwave therapy at 27.12 MHz
- Up to 720 hours of therapy per device
- 30-day money-back guarantee
ActiPatch® is FDA-cleared (510(k) K192234) for over-the-counter adjunctive treatment of musculoskeletal pain; it can be used alongside other treatments and is not a substitute for medical care. It is manufactured by BioElectronics Corporation. Consult your healthcare provider before starting any new therapy. View the FDA 510(k) record.